Celltrion reported KRW961.51B in Sales Revenues for its fiscal quarter ending in June of 2025.


Sales Change Date
Alaunos Therapeutics USD 0 4K Sep/2024
Avita Medical AUD 18.41M 7.89M Dec/2024
Celltrion KRW 961.51B 119.6B Jun/2025
Dianthus Therapeutics USD 193K 1.13M Jun/2025
Ionis Pharmaceuticals USD 452M 320M Jun/2025
IQVIA Holdings USD 4.02B 190M Jun/2025
Moderna USD 142M 34M Jun/2025
Organon & Co 1.59B 80M Jun/2025
Revvity USD 720M 55M Jun/2025
Tectonic Therapeutic 0 0 Dec/2024
Viatris USD 3.57B 320M Jun/2025
Xeris Pharmaceuticals USD 71.54M 11.44M Jun/2025